Surgery Robot Era: No Human Intentions Needed by 2027 – Musk
- Elon Musk, CEO of Tesla and Neuralink, predicts that surgical robot technology will rapidly advance, surpassing the capabilities of human surgeons within the next five years.
- In a post on X, formerly known as Twitter, Musk stated that robots would "surpass the best human surgeon within five years after surpassing excellent human surgeons within...
- Musk emphasized the necessity of robotics in neuralink's operations.
Musk Predicts Robots Will Outperform Surgeons Within five Years
Table of Contents
Elon Musk, CEO of Tesla and Neuralink, predicts that surgical robot technology will rapidly advance, surpassing the capabilities of human surgeons within the next five years. Musk highlighted the potential of robotic surgery, referencing Neuralink’s brain-computer interface (BCI) technology as an example.
In a post on X, formerly known as Twitter, Musk stated that robots would “surpass the best human surgeon within five years after surpassing excellent human surgeons within a few years.” This statement followed the sharing of a post highlighting the successful results of a surgical robot product in over 100 surgical tests.
Musk emphasized the necessity of robotics in neuralink’s operations. “neuralink had to use a robot to insert the brain-computer electrode,” he explained. “It was unachievable for humans to achieve the required speed and precision.”
Neuralink’s website details the intricacies of their BCI implantation process, stating, “The thread used for our transplantation is very thin and cannot be inserted into human hands. Our surgical robot is designed to accurately insert this thread stably and efficiently.”
Neuralink’s Clinical Trials and Patient Success
Musk also shared the progress of brad Ford Smith, a patient with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, who has successfully regained communication abilities through Neuralink’s implanted chip. Musk identified Smith as the third paralyzed patient to receive a Neuralink chip and the first ALS patient in the trial. Smith confirmed his progress, stating, “I’m entering this article with my brain now. This is my main means of communication,” in a post also on X.
As last year, Neuralink has been conducting experiments involving the implantation of BCIs in paralyzed patients, aiming to enable them to control devices through thought. While initial safety concerns delayed FDA approval for clinical trials, Neuralink is now proceeding with these trials and plans to implant BCI devices in 20 to 30 additional individuals this year.
Neuralink’s Funding and Valuation
Bloomberg News reported in April, citing an anonymous source, that neuralink is seeking to raise approximately $500 million based on a preliminary valuation of $8.5 billion. The company’s last external funding round, Series D, occurred in August 2023, raising $280 million.
Financial market data company, Peachbook, estimated Neuralink’s value at $3.5 billion in November 2023. if the current financing round reflects the $8.5 billion valuation, the company’s value would have increased by approximately $5 billion in roughly 18 months.
While tesla’s stock value has recently declined, Neuralink’s valuation has reportedly increased. As of April 28, Tesla’s share price was $285.88, up 0.33% on the day, but 41% lower than it’s peak of $488.54 recorded on December 15 of the previous year.
Can Robots Really Outperform Surgeons in 5 Years? Exploring Elon Musk’s Prediction
Introduction: What’s the Buzz About Robotic Surgery?
Q: What did Elon musk recently predict about surgical robots?
A: Elon Musk, the CEO of Tesla and Neuralink, predicts that surgical robots will surpass the capabilities of human surgeons within the next five years.
Q: Where did Musk make this prediction?
A: Musk made this prediction on the social media platform X (formerly Twitter).
Q: How does Musk connect this to Neuralink?
A: Musk highlighted Neuralink’s brain-computer interface (BCI) technology as an example of the potential of robotic surgery, emphasizing the role of robots in Neuralink’s operations.
Diving Deeper: The Role of Robotics in Neuralink
Q: What role do robots play in Neuralink’s operations?
A: Robots are crucial for Neuralink’s operations, specifically for implanting the brain-computer interface electrode, as stated by Musk because achieving the necessary speed and precision is unattainable for humans.
Q: What does Neuralink’s website say about the BCI implantation?
A: According to Neuralink’s website, their surgical robot is specially designed to accurately insert the thin thread used for transplantation, which is too small to be inserted by human hands, stably and efficiently.
Neuralink’s Clinical Trials and Patient Progress
Q: What progress at Neuralink has Elon Musk shared recently?
A: Musk shared the progress of Brad Ford Smith, an ALS patient, who has regained interaction abilities through a neuralink chip. Smith confirmed he used the chip to wriet the article. He is the third paralyzed patient in the trial, and the first with ALS.
Q: What is the aim of Neuralink’s clinical trials?
A: Neuralink is implanting BCIs in paralyzed patients to enable them to control devices using their thoughts.
Q: How many people do Neuralink plan to implant BCI devices in this year?
A: Neuralink plans to implant BCI devices in 20 to 30 additional individuals this year.
Financials: funding, Valuation, and Tesla’s Stock
Q: What is Neuralink’s current funding situation?
A: Neuralink is seeking to raise approximately $500 million, based on a preliminary valuation of $8.5 billion, as reported by Bloomberg News (citing an anonymous source) in April. The company’s last external funding round, Series D, was in August 2023, where they raised $280 million.
Q: How has Neuralink’s valuation changed recently?
A: If the current financing round reflects the $8.5 billion valuation,it suggests an increase of approximately $5 billion in value as november 2023,when Peachbook estimated Neuralink’s value at $3.5 billion.
Q: How does Neuralink’s valuation compare to Tesla’s stock performance?
A: While Tesla’s stock price has declined, notably from its peak on December 15 of the previous year, Neuralink’s valuation has reportedly increased.
Q: Can you summarize Neuralink’s Valuation timeline?
A:
| Date | Valuation | Source |
| ————– | —————– | ————————– |
| August 2023 | $280 million (Series D funding) | Article |
| November 2023 | $3.5 billion | Peachbook |
| April 2024 | $8.5 billion (seeking raise) | Bloomberg (anonymous source)|
| April 28 2024 | Tesla’s share price $285.88 | Article |